Subscribe to Newsletter

Diagnostics

Diagnostics Genetics and epigenetics

A Thorough NUDT15 Variant Catalogue

| Michael Schubert

Researchers have catalogued almost every NUDT15 variant to understand patients’ likelihood of thiopurine toxicity

Diagnostics Genetics and epigenetics

Precision Medicine: The Next Generation

| David Fenstermacher

Precision medicine is creating a sea change in healthcare and biomedical research. Is your lab prepared for the approaching tsunami of genetic tests?

Diagnostics Genetics and epigenetics

The African Imperative

| Aminu Yakubu

Genomics research is hampered by the fact that current reference genomes don’t take into account the vast diversity of human populations

Diagnostics Infectious disease

Behind the COVID Curve

| Luke Turner

Diagnostic testing for coronavirus suffered from a slow initial response in the US – but officials are ramping up efforts to get back on track

Diagnostics Microscopy and imaging

The Future of Microscope Imaging

| Jürgen Reymann

Microscopy is an ever-evolving field – and its next step may be into fully integrated, digitized systems that offer a wealth of new information

Diagnostics Microscopy and imaging

Case of the Month

A 59-year-old man presented with left upper quadrant discomfort and was found to have hepatosplenomegaly – but what is your diagnosis?

Diagnostics Liquid biopsy

Test, Treat, Repeat

| Alexandra Pender, Natacha Entz-Werle

New ctDNA biomarkers could lead to more informed treatment decisions for patients with advanced non-small cell lung cancer and pediatric osteosarcoma

Diagnostics Genetics and epigenetics

Boosting Genomic Research in Africa

| Luke Turner

A new initiative for translational genomics is set to boost genetic research and inspire the next generation of scientists in Africa

Diagnostics Biochemistry and molecular biology

Good Night!

| Luke Turner

New research finds a link between sleep duration and microRNA expression levels in children

Diagnostics Genetics and epigenetics

Revisiting the Real Impact

| Sponsored by Thermo Fisher Scientific

Oncologist and clinical researcher Elena Garralda shares her opinion on the benefits of rapid turnaround times for next-generation sequencing results

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register